Analyst Consensus ?
ConsensusBuy80 ratings
Bullish6581.3%
Neutral1518.7%
Bearish00.0%
FN2 Earnings Intelligence
Microsoft Corporation analyst ratings
Microsoft Corporation (MSFT) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$492.44Previous close
$234Low
$503.35Average
$700High
Latest persisted target per named analyst; persisted previous close from FN2's market snapshot as of Sep 11, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Stifel | Hold | Hold | Maintain | Sep 4, 2026 |
| B of A Securities | Buy | Buy | Maintain | Sep 1, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Aug 12, 2026 |
| Tigress Financial | Buy | Buy | Maintain | Aug 5, 2026 |
| TD Cowen | Buy | Buy | Maintain | Jul 30, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Jul 30, 2026 |
| Piper Sandler | Overweight | Overweight | Maintain | Jul 30, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Jul 30, 2026 |
| DA Davidson | Buy | Buy | Maintain | Jul 30, 2026 |
| Citizens | Market Outperform | Market Outperform | Maintain | Jul 30, 2026 |
| Citigroup | Buy | Buy | Maintain | Jul 30, 2026 |
| Cantor Fitzgerald | Overweight | Overweight | Maintain | Jul 30, 2026 |
| Bernstein | Outperform | Outperform | Maintain | Jul 30, 2026 |
| Barclays | Overweight | Overweight | Maintain | Jul 30, 2026 |
| UBS | Buy | Buy | Maintain | Jul 27, 2026 |
| Guggenheim | Buy | Buy | Maintain | Jul 27, 2026 |
| Truist Securities | Buy | Buy | Maintain | Jul 22, 2026 |
| Oppenheimer | Outperform | Outperform | Maintain | Jul 22, 2026 |
| Mizuho | Outperform | Outperform | Maintain | Jul 15, 2026 |
| Argus Research | Buy | Buy | Maintain | Jul 10, 2026 |
| BMO Capital | Outperform | Outperform | Maintain | Jul 7, 2026 |
| Wolfe Research | Outperform | Outperform | Maintain | Jul 6, 2026 |
| Wedbush | Outperform | Outperform | Maintain | May 13, 2026 |
| Scotiabank | Sector Outperform | Sector Outperform | Maintain | Apr 30, 2026 |
| Benchmark | Buy | Buy | Maintain | Apr 30, 2026 |
| Baird | Outperform | Outperform | Maintain | Apr 15, 2026 |
| BNP Paribas | Outperform | Outperform | Maintain | Apr 10, 2026 |
| Keybanc | Overweight | Overweight | Maintain | Jan 29, 2026 |
| Rothschild & Co | Neutral | Buy | Downgrade | Nov 18, 2025 |
| Raymond James | Outperform | Outperform | Maintain | Oct 30, 2025 |
| Morgan Stanley | Overweight | Overweight | Maintain | Oct 30, 2025 |
| JP Morgan | Overweight | Overweight | Maintain | Oct 30, 2025 |
| WestPark Capital | Hold | Hold | Maintain | Jul 31, 2025 |
| Jefferies | Buy | Buy | Maintain | Jul 31, 2025 |
| Loop Capital | Buy | Buy | Maintain | Jul 24, 2025 |
| Goldman Sachs | Buy | Buy | Maintain | May 21, 2025 |
| TD Securities | Buy | Buy | Maintain | May 1, 2025 |
| Macquarie | Outperform | Outperform | Maintain | May 17, 2024 |
| Exane BNP Paribas | Outperform | Neutral | Upgrade | Jan 18, 2024 |
| Rosenblatt | Buy | Buy | Maintain | Oct 26, 2023 |
| HSBC | Buy | Hold | Upgrade | Oct 26, 2023 |
| Redburn Partners | Buy | Buy | Maintain | Aug 11, 2023 |
| MoffettNathanson | Perform | Market Perform | Maintain | Jun 20, 2023 |
| Deutsche Bank | Buy | Buy | Maintain | Jun 20, 2023 |
| CFRA | Buy | Strong Buy | Downgrade | Jun 20, 2023 |
| Atlantic Equities | Overweight | Overweight | Maintain | Jun 20, 2023 |
| Credit Suisse | Outperform | Outperform | Maintain | May 31, 2023 |
| Cowen & Co. | Outperform | Outperform | Maintain | Jan 19, 2023 |
| SMBC Nikko | Outperform | Outperform | Maintain | Aug 8, 2022 |
| KGI Securities | Outperform | Outperform | Maintain | Jun 2, 2021 |
| Nomura | Buy | Buy | Maintain | Jan 31, 2020 |
| Stifel Nicolaus | Buy | Buy | Maintain | Jan 30, 2020 |
| Citi | Neutral | Neutral | Maintain | Oct 24, 2019 |
| Canaccord Genuity | Buy | Buy | Maintain | Jul 19, 2019 |
| Bank of America | Buy | Buy | Maintain | Apr 25, 2019 |
| Argus | Buy | Buy | Maintain | Jul 23, 2018 |
| PiperJaffray | Overweight | Overweight | Maintain | Jul 17, 2018 |
| Moffett Nathanson | Neutral | Neutral | Maintain | Sep 6, 2017 |
| Cleveland Research | Buy | Buy | Maintain | Jun 22, 2017 |
| Wunderlich | Buy | Hold | Upgrade | Oct 21, 2016 |
| Wunderlich Securities | Buy | Hold | Upgrade | Oct 20, 2016 |
| William Blair | Outperform | Market Perform | Upgrade | Oct 20, 2016 |
| Hilliard Lyons | Neutral | Long Term Buy | Downgrade | Feb 1, 2016 |
| Pacific Crest | Overweight | Overweight | Maintain | Apr 24, 2015 |
| FBN Securities | Outperform | Outperform | Maintain | Oct 2, 2014 |
| MKM Partners | Buy | Buy | Maintain | Sep 10, 2014 |
| FBR Capital | Outperform | Outperform | Maintain | Jul 23, 2014 |
| Summit Research Partners | Hold | Hold | Maintain | May 30, 2014 |
| B. Riley FBR | Neutral | Neutral | Maintain | Feb 27, 2014 |
| B. Riley | Neutral | Neutral | Maintain | Feb 27, 2014 |
| Sterne Agee | Neutral | Neutral | Maintain | Feb 4, 2014 |
| Evercore Partners | Overweight | Overweight | Maintain | Nov 27, 2013 |
| McAdams Wright Ragen | Hold | Hold | Maintain | Nov 19, 2013 |
| Standpoint Research | Hold | Buy | Downgrade | Apr 30, 2013 |
| Credit Agricole | Outperform | Buy | Maintain | Apr 12, 2013 |
| BGC Financial | Hold | Buy | Downgrade | Apr 10, 2013 |
| SunTrust Robinson Humphrey | Neutral | Neutral | Maintain | Dec 14, 2012 |
| Longbow Research | Buy | Buy | Maintain | Aug 20, 2012 |
| Griffin Securities | Buy | Buy | Maintain | Jul 20, 2012 |
| Bank oferica | Buy | Buy | Maintain | Apr 20, 2012 |
Named analyst price targets
Upside is calculated against the persisted previous close $492.44. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Stifel Nicolaus | Analyst unavailable | $530 | $510.12 | +7.6% | Sep 4, 2026 |
| Bernstein | Mark Moerdler | $660 | $508.82 | +34.0% | Aug 10, 2026 |
| Tigress Financial | Ivan Feinseth | $690 | $488.91 | +40.1% | Aug 5, 2026 |
| UBS | Karl Kierstead | $525 | $451.98 | +6.6% | Jul 30, 2026 |
| D.A. Davidson | Gil Luria | $550 | $449.7 | +11.7% | Jul 30, 2026 |
| Scotiabank | Analyst unavailable | $510 | $455.48 | +3.6% | Jul 30, 2026 |
| Cantor Fitzgerald | Analyst unavailable | $522 | $446.31 | +6.0% | Jul 30, 2026 |
| Bernstein | Analyst unavailable | $647 | $390.54 | +31.4% | Jul 30, 2026 |
| Evercore ISI | Kirk Materne | $528 | $390.54 | +7.2% | Jul 30, 2026 |
| Goldman Sachs | Gabriela Borges | $640 | $390.54 | +30.0% | Jul 30, 2026 |
| Wolfe Research | Alex Zukin | $550 | $390.54 | +11.7% | Jul 30, 2026 |
| Barclays | Raimo Lenschow | $512 | $390.54 | +4.0% | Jul 30, 2026 |
| UBS | Analyst unavailable | $480 | $392.14 | -2.5% | Jul 27, 2026 |
| Morgan Stanley | Adam Wood | $600 | $402.29 | +21.8% | Jul 21, 2026 |
| CLSA | Analyst unavailable | $535 | $393.82 | +8.6% | Jul 20, 2026 |
| Evercore ISI | Kirk Materne | $525 | $384.93 | +6.6% | Jul 15, 2026 |
| Mizuho Securities | Gregg Moskowitz | $490 | $384.93 | -0.5% | Jul 15, 2026 |
| Argus Research | Joseph Bonner | $510 | $381.85 | +3.6% | Jul 10, 2026 |
| BMO Capital | Keith Bachman | $515 | $392.04 | +4.6% | Jul 7, 2026 |
| Wolfe Research | Alex Zukin | $525 | $385.69 | +6.6% | Jul 6, 2026 |
| Stifel Nicolaus | Analyst unavailable | $400 | $365.46 | -18.8% | Jun 25, 2026 |
| Tigress Financial | Ivan Feinseth | $680 | $413.96 | +38.1% | May 6, 2026 |
| Scotiabank | Patrick Colville | $550 | $403.31 | +11.7% | Apr 30, 2026 |
| Deutsche Bank | Analyst unavailable | $550 | $405.65 | +11.7% | Apr 30, 2026 |
| Stifel Nicolaus | Brad Reback | $415 | $405.28 | -15.7% | Apr 30, 2026 |
| Evercore ISI | Kirk Materne | $510 | $401.73 | +3.6% | Apr 30, 2026 |
| Bernstein | Mark Moerdler | $646 | $424.46 | +31.2% | Apr 30, 2026 |
| Truist Financial | Analyst unavailable | $575 | $424.46 | +16.8% | Apr 30, 2026 |
| Piper Sandler | Analyst unavailable | $540 | $424.46 | +9.7% | Apr 30, 2026 |
| Wells Fargo | Analyst unavailable | $625 | $424.46 | +26.9% | Apr 30, 2026 |
| Barclays | Analyst unavailable | $545 | $424.46 | +10.7% | Apr 30, 2026 |
| BMO Capital | Analyst unavailable | $505 | $425.65 | +2.6% | Apr 28, 2026 |
| Oppenheimer | Analyst unavailable | $515 | $424.6 | +4.6% | Apr 27, 2026 |
| Robert W. Baird | William Power | $500 | $393.11 | +1.5% | Apr 15, 2026 |
| Mizuho Securities | Analyst unavailable | $515 | $384.37 | +4.6% | Apr 14, 2026 |
| Piper Sandler | Billy Fitzsimmons | $500 | $384.37 | +1.5% | Apr 14, 2026 |
| BNP Paribas | Stefan Slowinski | $556 | $370.78 | +12.9% | Apr 10, 2026 |
| Melius Research | Analyst unavailable | $430 | $411.84 | -12.7% | Feb 9, 2026 |
| Stifel Nicolaus | Analyst unavailable | $392 | $414.19 | -20.4% | Feb 5, 2026 |
| Cantor Fitzgerald | Thomas Blakey | $590 | $423.94 | +19.8% | Jan 29, 2026 |
| Deutsche Bank | Brad Zelnick | $575 | $428.63 | +16.8% | Jan 29, 2026 |
| Stifel Nicolaus | Brad Reback | $540 | $426.35 | +9.7% | Jan 29, 2026 |
| BMO Capital | Keith Bachman | $575 | $426.63 | +16.8% | Jan 29, 2026 |
| Evercore ISI | Analyst unavailable | $580 | $424.4 | +17.8% | Jan 29, 2026 |
| Wedbush | Analyst unavailable | $575 | $481.63 | +16.8% | Jan 29, 2026 |
| RBC Capital | Analyst unavailable | $550 | $426.7 | +11.7% | Jan 29, 2026 |
| Scotiabank | Patrick Colville | $600 | $425.52 | +21.8% | Jan 29, 2026 |
| Piper Sandler | Brent Bracelin | $600 | $481.63 | +21.8% | Jan 29, 2026 |
| Bernstein | Mark Moerdler | $641 | $481.63 | +30.2% | Jan 29, 2026 |
| KeyBanc | Jackson Ader | $600 | $481.63 | +21.8% | Jan 29, 2026 |
| Wells Fargo | Analyst unavailable | $615 | $481.63 | +24.9% | Jan 29, 2026 |
| Goldman Sachs | Analyst unavailable | $600 | $481.63 | +21.8% | Jan 29, 2026 |
| Robert W. Baird | William Power | $540 | $481.63 | +9.7% | Jan 29, 2026 |
| Barclays | Raimo Lenschow | $600 | $481.63 | +21.8% | Jan 29, 2026 |
| Stifel Nicolaus | Brad Reback | $520 | $465.95 | +5.6% | Jan 26, 2026 |
| UBS | Analyst unavailable | $600 | $451.14 | +21.8% | Jan 23, 2026 |
| Redburn Partners | Alex Haissl | $450 | $445.94 | -8.6% | Jan 21, 2026 |
| Mizuho Securities | Analyst unavailable | $620 | $454.52 | +25.9% | Jan 21, 2026 |
| Cowen & Co. | Analyst unavailable | $625 | $459.86 | +26.9% | Jan 20, 2026 |
| Barclays | Analyst unavailable | $610 | $479.28 | +23.9% | Jan 12, 2026 |
| Goldman Sachs | Analyst unavailable | $655 | $479.28 | +33.0% | Jan 11, 2026 |
| Wells Fargo | Analyst unavailable | $665 | $483.47 | +35.0% | Jan 8, 2026 |
| Guggenheim | John DiFucci | $675 | $493.79 | +37.1% | Nov 19, 2025 |
| Robert W. Baird | Analyst unavailable | $600 | $503.29 | +21.8% | Nov 14, 2025 |
| Cantor Fitzgerald | Thomas Blakey | $639 | $529.17 | +29.8% | Oct 30, 2025 |
| D.A. Davidson | Gil Luria | $650 | $525.38 | +32.0% | Oct 30, 2025 |
| Piper Sandler | Hannah Rudoff | $650 | $541.55 | +32.0% | Oct 30, 2025 |
| Stifel Nicolaus | Brad Reback | $640 | $541.55 | +30.0% | Oct 30, 2025 |
| Bernstein | Analyst unavailable | $645 | $541.55 | +31.0% | Oct 30, 2025 |
| Morgan Stanley | Keith Weiss | $650 | $541.55 | +32.0% | Oct 30, 2025 |
| Evercore ISI | Kirk Materne | $640 | $541.55 | +30.0% | Oct 30, 2025 |
| Wells Fargo | Michael Turrin | $700 | $541.55 | +42.1% | Oct 30, 2025 |
| RBC Capital | Rishi Jaluria | $640 | $538.76 | +30.0% | Oct 29, 2025 |
| Mizuho Securities | Gregg Moskowitz | $640 | $542.08 | +30.0% | Oct 28, 2025 |
| Wolfe Research | Alex Zukin | $675 | $542.46 | +37.1% | Oct 28, 2025 |
| Goldman Sachs | Kash Rangan | $630 | $544.58 | +27.9% | Oct 28, 2025 |
| Evercore ISI | Analyst unavailable | $625 | $542.46 | +26.9% | Oct 28, 2025 |
| Guggenheim | Analyst unavailable | $586 | $523.61 | +19.0% | Oct 27, 2025 |
| Redburn Partners | Analyst unavailable | $560 | $517.66 | +13.7% | Oct 22, 2025 |
| Wells Fargo | Analyst unavailable | $675 | $517.35 | +37.1% | Oct 6, 2025 |
| Morgan Stanley | Analyst unavailable | $625 | $511.46 | +26.9% | Sep 26, 2025 |
| Truist Financial | Terry Tillman | $675 | $519.42 | +37.1% | Aug 18, 2025 |
| Morgan Stanley | Keith Weiss | $582 | $513.24 | +18.2% | Jul 31, 2025 |
| UBS | Analyst unavailable | $650 | $513.24 | +32.0% | Jul 31, 2025 |
| Oppenheimer | Analyst unavailable | $630 | $513.24 | +27.9% | Jul 31, 2025 |
| Wells Fargo | Analyst unavailable | $650 | $554.86 | +32.0% | Jul 31, 2025 |
| Barclays | Analyst unavailable | $625 | $554.86 | +26.9% | Jul 31, 2025 |
| KeyBanc | Jackson Ader | $630 | $513.24 | +27.9% | Jul 31, 2025 |
| Jefferies | Analyst unavailable | $675 | $554.86 | +37.1% | Jul 31, 2025 |
| Mizuho Securities | Gregg Moskowitz | $540 | $504.38 | +9.7% | Jul 16, 2025 |
| Cantor Fitzgerald | Thomas Blakey | $581 | $503.1 | +18.0% | Jul 16, 2025 |
| Oppenheimer | Brian Schwartz | $600 | $501.76 | +21.8% | Jul 9, 2025 |
| Evercore ISI | Kirk Materne | $515 | $454.86 | +4.6% | May 22, 2025 |
| Morgan Stanley | Keith Weiss | $472 | $371.61 | -4.2% | Apr 16, 2025 |
| Jefferies | Brent Thill | $475 | $359.84 | -3.5% | Apr 7, 2025 |
| Tigress Financial | Ivan Feinseth | $595 | $386.84 | +20.8% | Mar 20, 2025 |
| Scotiabank | Analyst unavailable | $470 | $387.82 | -4.6% | Mar 19, 2025 |
| D.A. Davidson | Gil Luria | $425 | $432.53 | -13.7% | Oct 31, 2024 |
| Citigroup | Tyler Radke | $497 | $427.51 | +0.9% | Oct 23, 2024 |
| Piper Sandler | Brent Bracelin | $470 | $416.72 | -4.6% | Oct 18, 2024 |
| KeyBanc | Jackson Ader | $505 | $417.51 | +2.6% | Oct 18, 2024 |
| Bank of America Securities | Bradley Sills | $510 | $416.72 | +3.6% | Oct 17, 2024 |
| Goldman Sachs | Kash Rangan | $500 | $415.93 | +1.5% | Oct 10, 2024 |
| Wedbush | Scott Devitt | $600 | $431.31 | +21.8% | Sep 26, 2024 |
| D.A. Davidson | Gil Luria | $475 | $435.27 | -3.5% | Sep 23, 2024 |
| Mizuho Securities | Gregg Moskowitz | $480 | $435.15 | -2.5% | Sep 18, 2024 |
| Deutsche Bank | Brad Zelnick | $475 | $435.13 | -3.5% | Sep 17, 2024 |
| Wolfe Research | Alex Zukin | $495 | $411.68 | +0.5% | Aug 27, 2024 |
| Stifel Nicolaus | Brad Reback | $475 | $418.79 | -3.5% | Jul 31, 2024 |
| Evercore ISI | Kirk Materne | $500 | $417.24 | +1.5% | Jul 31, 2024 |
| Morgan Stanley | Keith Weiss | $506 | $422.92 | +2.8% | Jul 31, 2024 |
| Loop Capital Markets | Yun Kim | $500 | $442.94 | +1.5% | Jul 23, 2024 |
| Piper Sandler | Brent Bracelin | $485 | $442.94 | -1.5% | Jul 23, 2024 |
| Evercore ISI | David Palmer | $540 | $452.21 | +9.7% | Jul 16, 2024 |
| BMO Capital | Keith Bachman | $500 | $454.7 | +1.5% | Jul 12, 2024 |
| Wedbush | Daniel Ives | $550 | $442.57 | +11.7% | Jun 16, 2024 |
| Tigress Financial | Ivan Feinseth | $550 | $441.58 | +11.7% | Jun 13, 2024 |
| New Street | Pierre Ferragu | $570 | $423.85 | +15.8% | Jun 10, 2024 |
| Oppenheimer | Timothy Horan | $500 | $423.85 | +1.5% | Jun 7, 2024 |
| Barclays | Raimo Lenschow | $475 | $413.52 | -3.5% | Jun 4, 2024 |
| Wedbush | Dan Ives | $275 | $430.16 | -44.2% | May 24, 2024 |
| Mizuho Securities | Gregg Moskowitz | $450 | $430.85 | -8.6% | May 22, 2024 |
| Goldman Sachs | Kash Rangan | $515 | $429.04 | +4.6% | May 22, 2024 |
| Wells Fargo | Michael Turrin | $500 | $429.04 | +1.5% | May 22, 2024 |
| Macquarie | Frederick Havemeyer | $475 | $420.21 | -3.5% | May 17, 2024 |
| RBC Capital | Kash Rangan | $500 | $420.99 | +1.5% | May 17, 2024 |
| Piper Sandler | Brent Bracelin | $465 | $413.72 | -5.6% | May 13, 2024 |
| Bernstein | Mark Moerdler | $489 | $399.04 | -0.7% | Apr 26, 2024 |
| Citigroup | Tyler Radke | $475 | $404.33 | -3.5% | Apr 18, 2024 |
| Wells Fargo | Michael Turrin | $480 | $414.58 | -2.5% | Apr 17, 2024 |
| Macquarie | Frederick Havemeyer | $455 | $414.58 | -7.6% | Apr 16, 2024 |
| CFRA | Angelo Zino | $475 | $420.06 | -3.5% | Apr 15, 2024 |
| Loop Capital Markets | Keith Bachman | $465 | $421.81 | -5.6% | Apr 12, 2024 |
| BMO Capital | Keith Bachman | $465 | $427.93 | -5.6% | Apr 12, 2024 |
| Morgan Stanley | Keith Weiss | $520 | $423.26 | +5.6% | Apr 11, 2024 |
| Morgan Stanley | Keith Weiss | $465 | $423.14 | -5.6% | Apr 1, 2024 |
| Melius Research | Ben Reitzes | $475 | $420.72 | -3.5% | Apr 1, 2024 |
| Jefferies | Brent Thill | $550 | $420.72 | +11.7% | Mar 31, 2024 |
| Wedbush | Daniel Ives | $500 | $422.86 | +1.5% | Mar 25, 2024 |
| KeyBanc | Jackson Ader | $490 | $425.23 | -0.5% | Mar 20, 2024 |
| Wells Fargo | Michael Turrin | $460 | $415.1 | -6.6% | Mar 13, 2024 |
| Truist Financial | Joel Fishbein | $600 | $402.04 | +21.8% | Jan 31, 2024 |
| Wedbush | Daniel Ives | $450 | $409.72 | -8.6% | Jan 29, 2024 |
| BNP Paribas | Stefan Slowinski | $471 | $393.73 | -4.4% | Jan 18, 2024 |
| Piper Sandler | Brent Bracelin | $455 | $388.47 | -7.6% | Jan 12, 2024 |
| Wedbush | Daniel Ives | $425 | $375.77 | -13.7% | Nov 16, 2023 |
| Bernstein | Stacy Rasgon | $406 | $356.53 | -17.6% | Nov 6, 2023 |
| Piper Sandler | Brent Bracelin | $425 | $339.98 | -13.7% | Oct 25, 2023 |
| Raymond James | Andrew Marok | $400 | $330.54 | -18.8% | Oct 23, 2023 |
| KeyBanc | Michael Turits | $400 | $328 | -18.8% | Oct 20, 2023 |
| Evercore ISI | Kirk Materne | $400 | $331.32 | -18.8% | Oct 19, 2023 |
| Loop Capital Markets | Yun Kim | $425 | $331.65 | -13.7% | Oct 17, 2023 |
| Wedbush | Daniel Ives | $400 | $320.92 | -18.8% | Sep 21, 2023 |
| Bernstein | Mark Moerdler | $400 | $328.65 | -18.8% | Sep 20, 2023 |
| UBS | Karl Keirstead | $400 | $328.36 | -18.8% | Aug 29, 2023 |
| Oppenheimer | Timothy Horan | $410 | $323.18 | -16.7% | Aug 25, 2023 |
| BMO Capital | Keith Bachman | $400 | $334.81 | -18.8% | Jul 26, 2023 |
| Guggenheim | John Difucci | $232 | $348.09 | -52.9% | Jul 20, 2023 |
| Wedbush | Daniel Ives | $220 | $335.05 | -55.3% | Jun 29, 2023 |
| Credit Suisse | Sami Badri | $420 | $329.63 | -14.7% | May 31, 2023 |
| Oppenheimer | Timothy Horan | $330 | $304.4 | -33.0% | May 3, 2023 |
| Morgan Stanley | Keith Weiss | $335 | $295.16 | -32.0% | Apr 26, 2023 |
| Mizuho Securities | Gregg Moskowitz | $315 | $288.8 | -36.0% | Apr 17, 2023 |
| Morgan Stanley | Keith Weiss | $307 | $291.37 | -37.7% | Apr 6, 2023 |
| Needham | Rajvindra Gill | $270 | $272.29 | -45.2% | Mar 22, 2023 |
| RBC Capital | Rishi Jaluria | $285 | $280.93 | -42.1% | Mar 17, 2023 |
| BMO Capital | Keith Bachman | $265 | $252.6 | -46.2% | Feb 21, 2023 |
| D.A. Davidson | Analyst unavailable | $325 | $273.68 | -34.0% | Feb 8, 2023 |
| Piper Sandler | Analyst unavailable | $290 | $267.56 | -41.1% | Feb 8, 2023 |
| Wedbush | Daniel Ives | $280 | $256.77 | -43.1% | Feb 7, 2023 |
| Piper Sandler | Brent Bracelin | $247 | $228.12 | -49.8% | Jan 10, 2023 |
| Barclays | Analyst unavailable | $280 | $227.12 | -43.1% | Jan 10, 2023 |
| Piper Sandler | Brent Bracelin | $115 | $227.81 | -76.6% | Jan 9, 2023 |
| D.A. Davidson | Gil Luria | $270 | $223.87 | -45.2% | Jan 5, 2023 |
| UBS | Analyst unavailable | $250 | $239.58 | -49.2% | Jan 4, 2023 |
| Macquarie | Sarah Hindlian | $234 | $242.98 | -52.5% | Nov 11, 2022 |
| Evercore ISI | Kirk Materne | $300 | $231.32 | -39.1% | Oct 26, 2022 |
| Atlantic Equities | James Cordwell | $290 | $231.32 | -41.1% | Oct 26, 2022 |
| Barclays | Raimo Lenschow | $296 | $250.66 | -39.9% | Oct 26, 2022 |
| RBC Capital | Rishi Jaluria | $310 | $231.32 | -37.0% | Oct 26, 2022 |
| Jefferies | Brent Thill | $270 | $231.32 | -45.2% | Oct 26, 2022 |
| Rosenblatt Securities | Blair Abernethy | $285 | $231.32 | -42.1% | Oct 26, 2022 |
| Raymond James | Andrew Marok | $280 | $250.66 | -43.1% | Oct 26, 2022 |
| Piper Sandler | Brent Bracelin | $265 | $250.66 | -46.2% | Oct 26, 2022 |
| Wells Fargo | Michael Turrin | $300 | $250.66 | -39.1% | Oct 26, 2022 |
| BMO Capital | Keith Bachman | $270 | $231.32 | -45.2% | Oct 26, 2022 |
| Wedbush | Daniel Ives | $290 | $250.66 | -41.1% | Oct 25, 2022 |
| Wedbush | Daniel Ives | $320 | $242.12 | -35.0% | Oct 23, 2022 |
| Wells Fargo | Michael Turrin | $315 | $237.53 | -36.0% | Oct 17, 2022 |
| Jefferies | Brent Thill | $275 | $229.25 | -44.2% | Oct 11, 2022 |
| MoffettNathanson | Analyst unavailable | $285 | $240.08 | -42.1% | Sep 22, 2022 |
| Guggenheim | Analyst unavailable | $292 | $287.02 | -40.7% | Aug 12, 2022 |
| Wolfe Research | Analyst unavailable | $275 | $276.41 | -44.2% | Jul 29, 2022 |
| Cowen & Co. | Analyst unavailable | $320 | $264.24 | -35.0% | Jul 27, 2022 |
| Deutsche Bank | Analyst unavailable | $330 | $251.9 | -33.0% | Jul 27, 2022 |
| J.P. Morgan | Analyst unavailable | $305 | $251.9 | -38.1% | Jul 27, 2022 |
| Stifel Nicolaus | Analyst unavailable | $300 | $251.9 | -39.1% | Jul 27, 2022 |
| BMO Capital | Analyst unavailable | $320 | $251.9 | -35.0% | Jul 27, 2022 |
| Citigroup | Analyst unavailable | $300 | $251.9 | -39.1% | Jul 27, 2022 |
| Rosenblatt Securities | Blair Abernethy | $330 | $251.9 | -33.0% | Jul 26, 2022 |
| BMO Capital | Keith Bachman | $305 | $251.6 | -38.1% | Jul 26, 2022 |
| Wells Fargo | Michael Turrin | $350 | $257.56 | -28.9% | Jul 25, 2022 |
| Wells Fargo | Analyst unavailable | $350 | $260.36 | -28.9% | Jul 25, 2022 |
| Cowen & Co. | Analyst unavailable | $330 | $262.86 | -33.0% | Jul 22, 2022 |
| Mizuho Securities | Analyst unavailable | $340 | $256.52 | -31.0% | Jul 19, 2022 |
| Citigroup | Analyst unavailable | $330 | $254.25 | -33.0% | Jul 19, 2022 |
| Piper Sandler | Brent Bracelin | $312 | $256.72 | -36.6% | Jul 18, 2022 |
| KeyBanc | Michael Turits | $330 | $256.72 | -33.0% | Jul 16, 2022 |
| Morgan Stanley | Keith Weiss | $354 | $254.08 | -28.1% | Jul 14, 2022 |
| Redburn Partners | Alex Haissl | $370 | $259.58 | -24.9% | Jul 4, 2022 |
| Jefferies | Brent Thill | $320 | $264.89 | -35.0% | Jun 28, 2022 |
| Barclays | Raimo Lenschow | $335 | $252.99 | -32.0% | Jun 11, 2022 |
| BMO Capital | Keith Bachman | $345 | $264.79 | -29.9% | Jun 10, 2022 |
| Stifel Nicolaus | Brad Reback | $320 | $270.02 | -35.0% | Jun 4, 2022 |
| Mizuho Securities | Gregg Moskowitz | $350 | $273.18 | -28.9% | Jun 2, 2022 |
| RBC Capital | Rishi Jaluria | $200 | $259.62 | -59.4% | May 24, 2022 |
| Jefferies | Brent Thill | $325 | $259.8 | -34.0% | May 23, 2022 |
| Wedbush | Daniel Ives | $340 | $252.56 | -31.0% | May 20, 2022 |
| Stifel Nicolaus | Brad Reback | $350 | $277.52 | -28.9% | Apr 29, 2022 |
| Deutsche Bank | Brad Zelnick | $350 | $289.28 | -28.9% | Apr 28, 2022 |
| Wolfe Research | Alex Zukin | $350 | $283.22 | -28.9% | Apr 28, 2022 |
| Rosenblatt Securities | Blair Abernethy | $349 | $283.22 | -29.1% | Apr 27, 2022 |
| Jefferies | Brent Thill | $400 | $283.22 | -18.8% | Apr 27, 2022 |
| Citigroup | Tyler Radke | $364 | $270.22 | -26.1% | Apr 27, 2022 |
| Wells Fargo | Michael Turrin | $400 | $283.22 | -18.8% | Apr 27, 2022 |
| Citigroup | Tyler Radke | $364 | $283.22 | -26.1% | Apr 27, 2022 |
| Evercore ISI | Kirk Materne | $330 | $283.22 | -33.0% | Apr 27, 2022 |
| BMO Capital | Analyst unavailable | $340 | $276.82 | -31.0% | Apr 26, 2022 |
| Piper Sandler | Brent Bracelin | $352 | $270.22 | -28.5% | Apr 26, 2022 |
| Goldman Sachs | Kash Rangan | $365 | $270.22 | -25.9% | Apr 26, 2022 |
| Credit Suisse | Philip Winslow | $400 | $280.72 | -18.8% | Apr 25, 2022 |
| BMO Capital | Keith Bachman | $340 | $280.72 | -31.0% | Apr 25, 2022 |
| Wells Fargo | Michael Turrin | $400 | $274.03 | -18.8% | Apr 22, 2022 |
| Citigroup | Analyst unavailable | $355 | $284.05 | -27.9% | Apr 19, 2022 |
| Morgan Stanley | Keith Weiss | $372 | $279.83 | -24.5% | Apr 16, 2022 |
| Stifel Nicolaus | Brad Reback | $380 | $289.86 | -22.8% | Mar 5, 2022 |
| Argus Research | Joseph Bonner | $371 | $305.94 | -24.7% | Feb 6, 2022 |
| Tigress Financial | Ivan Feinseth | $411 | $305.94 | -16.5% | Feb 5, 2022 |
| Bernstein | Mark Moerdler | $365 | $308.26 | -25.9% | Jan 30, 2022 |
| Citigroup | Tyler Radke | $386 | $296.1 | -21.6% | Jan 26, 2022 |
| RBC Capital | Rishi Jaluria | $380 | $296.1 | -22.8% | Jan 26, 2022 |
| UBS | Karl Keirstead | $360 | $296.1 | -26.9% | Jan 26, 2022 |
| Credit Suisse | Philip Winslow | $400 | $296.1 | -18.8% | Jan 26, 2022 |
| J.P. Morgan | Mark Murphy | $320 | $296.1 | -35.0% | Jan 26, 2022 |
| Wells Fargo | Michael Turrin | $425 | $296.1 | -13.7% | Jan 26, 2022 |
| Oppenheimer | Timothy Horan | $340 | $296.1 | -31.0% | Jan 26, 2022 |
| Wedbush | Daniel Ives | $375 | $296.1 | -23.8% | Jan 26, 2022 |
| BMO Capital | Keith Bachman | $355 | $296.1 | -27.9% | Jan 26, 2022 |
| Piper Sandler | Brent Bracelin | $352 | $296.1 | -28.5% | Jan 26, 2022 |
| Evercore ISI | Kirk Materne | $370 | $296.1 | -24.9% | Jan 26, 2022 |
| Deutsche Bank | Brad Zelnick | $390 | $287.89 | -20.8% | Jan 25, 2022 |
| Goldman Sachs | Kash Rangan | $400 | $295.76 | -18.8% | Jan 23, 2022 |
| Cowen & Co. | Derrick Wood | $360 | $300.98 | -26.9% | Jan 20, 2022 |
| Jefferies | Brent Thill | $400 | $313.88 | -18.8% | Jan 6, 2022 |
| SMBC Nikko | Steven Koenig | $410 | $326.61 | -16.7% | Dec 21, 2021 |
| KeyBanc | Michael Turits | $365 | $306.93 | -25.9% | Oct 25, 2021 |
| Wolfe Research | Alex Zukin | $315 | $284.56 | -36.0% | Jul 28, 2021 |
| Cross Research | Shannon Cross | $300 | $263.48 | -39.1% | Jun 25, 2021 |
| KGI Securities | Freddy Chen | $300 | $245.97 | -39.1% | Jun 1, 2021 |
| Raymond James | Robert Majek | $290 | $252.5 | -41.1% | Apr 28, 2021 |
| BNP Paribas | Stefan Slowinski | $330 | $255.09 | -33.0% | Apr 22, 2021 |
Track every rating change on MSFT the moment it posts. Free to start.
Start free